New Zealand Anti-Smoking Website Criticized for Misrepresenting E-Cigarettes

Aug.10.2022
New Zealand Anti-Smoking Website Criticized for Misrepresenting E-Cigarettes
The "Don't Smoke" anti-e-cigarette website lacks scientific facts and may send false messages about e-cigarettes.

The "Quit Vaping" website was established by the Asthma and Respiratory Foundation of New Zealand (ARFNZ), but unfortunately, it fails to provide all scientific facts related to electronic cigarettes. In a recent press release, the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) revealed that it had examined the website and sadly found that "while the website focuses on the science, it fails to provide a comprehensive picture of electronic cigarettes.


The homepage of the anti-electronic cigarette website reads "Do not smoke.


To make matters worse, the website has continued to make false claims about the safety of electronic cigarettes, potentially spreading misinformation to the public and preventing smokers from switching to safer alternatives.


Loucas emphasized that New Zealand's tobacco harm reduction strategy is actually working, but unfortunately, ARANZ's actions go against this progress. "New Zealand has implemented an effective tobacco harm reduction (THR) strategy, and the country's overall smoking rates are at their lowest levels in history. With the government refocusing on the Smokefree Aotearoa 2025 plan, it's unfortunate that ARFNZ is working hard to prevent the remaining smokers from transitioning to safer alternatives," she said.


Lucas mentioned claims about hazardous chemicals found in vapor. These misleading statements include the notion that nicotine harms the brains of adolescents, children, and fetuses. Additionally, e-cigarette vapor may potentially contain harmful substances such as formaldehyde, carcinogenic chemicals, and heavy metals. Children and adults could become poisoned by ingesting e-liquid or absorbing it through their skin or eyes. Furthermore, e-cigarettes have been linked to thousands of cases of severe lung damage.


If any of these claims are combined, do you think the New Zealand Ministry of Health would actively encourage smokers, including pregnant women, to switch to e-cigarettes as an effective smoking cessation tool?


These claims have been debunked by science.


She added that countless scientific studies reviewed by peers and recognition from globally renowned health organizations, such as the NHS, completely refute these claims.


Compared to the deadly effects of smoking, the website for electronic cigarettes provides some appropriate background information. However, it does not mention that no New Zealanders have reportedly died from using electronic cigarettes, nor does it acknowledge the English Public Health Department's firm stance that the hazards of vaping are 95% lower than those of smoking combustible cigarettes.


Let us fight with facts instead of fueling emotions. ARFNZ is creating an non-existent hysteria. They claim to be running an education campaign, but it is merely political persecution," she concluded.


Statement:


This article is compiled based on third-party information and is intended for industry communication and learning purposes.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is solely for exchange and research within the industry.


Due to limitations in the translator's proficiency, the translated article may not fully reflect the original expression. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


Copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12
Canada Vape Enforcement Action Puts VAPME Website, Trademark and China Supply-Chain Links in Focus
Canada Vape Enforcement Action Puts VAPME Website, Trademark and China Supply-Chain Links in Focus
Quebec police seized about 300,000 suspected illegal vape products and froze more than C$1.8 million in funds. Local media said vapme.ca, a website selling flavoured vape products, was shut down during the operation.
Regulations
Jun.18
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai
Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design
Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design
From May 8 to 10, 2026, Mylor (Booth E70) will exhibit at The Vaper Expo UK, where it will showcase its systematic experience design solutions for e-liquids. At present, the e-liquid market commonly faces a challenge: many products have “no obvious shortcomings, but lack memorable features.” In response, Mylor has proposed refined solutions across multiple dimensions, including device-adaptive sweetness, progressive cooling sensation, fruit-oriented sourness, and segmented nicotine experience.
May.08
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
LOST MARY Launches VIZ With Transparent Wraparound Pod and LED Display
LOST MARY Launches VIZ With Transparent Wraparound Pod and LED Display
LOST MARY announced VIZ on May 6, 2026, describing it as the brand’s first product with a transparent 360-degree wraparound pod.
May.07 by 2FIRSTS.ai